New Gene Therapy Targets Congenital Hearing Loss with Promising Early Results
A novel gene therapy is being developed to address congenital hearing loss by targeting specific genetic mutations, showing potential in early trials.
6 articles tagged with "gene therapy"
A novel gene therapy is being developed to address congenital hearing loss by targeting specific genetic mutations, showing potential in early trials.
Recent advancements in custom polymers and artificial intelligence are set to enhance the delivery systems for gene therapies, crucial for effective cellular uptake of nucleic acids.
Recent findings highlight that the shape of DNA significantly influences the precision of CRISPR gene editing, presenting challenges for therapeutic applications.
Recent developments in DNA base editing technology focus on minimizing unintended edits while maintaining high editing efficiency, offering significant implications for medical applications.
A new genome editing technology using DNA circles shows potential for accurately delivering gene-sized payloads to address complex genetic disorders.
Recent research has demonstrated significant improvements in the targeting efficiency of gene-therapy nanoparticles, utilizing DNA barcoding to enhance drug delivery methods.